Assignee
GRADALIS INC
US·13 granted patents·13 pending applications·37 citations·filing 2010–2025
Top patents by PatentIndex Score
26 records- 0187US9382589B2Individualized cancer therapyGRADALIS INC·Filed 2013·Granted Jul 5, 2016·5 cites·20 claims
- 0286US9695422B2Furin-knockdown bi-functional RNAGRADALIS INC·Filed 2015·Granted Jul 4, 2017·3 cites·18 claims
- 0386US9290763B2Construction of bifunctional short hairpin RNAGRADALIS INC·Filed 2014·Granted Mar 22, 2016·3 cites·35 claims
- 0483US9790518B2Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccineGRADALIS INC·Filed 2015·Granted Oct 17, 2017·3 cites·11 claims
- 0583US9528991B2Individualized cancer therapyGRADALIS INC·Filed 2014·Granted Dec 27, 2016·3 cites·21 claims
- 0682US8735119B2Polypeptides having colanic acid-degrading activityGRADALIS INC·Filed 2013·Granted May 27, 2014·2 cites·6 claims
- 0782US8361983B2Therapeutic RNA interference technology targeted to the PDX-1 oncogene in PDX-1 expressing neuroendocrine tumorsGRADALIS INC·Filed 2010·Granted Jan 29, 2013·7 cites·34 claims
- 0881US9353373B2Bi-functional short-hairpin RNA (bi-shRNA) specific for single-nucleotide KRAS mutationsGRADALIS INC·Filed 2013·Granted May 31, 2016·7 cites·17 claims
- 0981US8524475B1Polypeptides having colanic acid-degrading activityGRADALIS INC·Filed 2013·Granted Sep 3, 2013·2 cites·24 claims
- 1077US11400170B2Methods for treating cancersGRADALIS INC·Filed 2021·Granted Aug 2, 2022·1 cites·18 claims
- 1176US10253331B2Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccineGRADALIS INC·Filed 2017·Granted Apr 9, 2019·1 cites·20 claims
- 1264US2014349389A1Processes for the digestion of colanic acidGRADALIS INC·Filed 2013·Application pending·0 cites
- 1362US2025003010A1Methods for treatment response to cancersGRADALIS INC·Filed 2022·Application pending·0 cites
- 1461US9914977B2Individualized cancer therapyGRADALIS INC·Filed 2016·Granted Mar 13, 2018·0 cites·14 claims
- 1560US9181225B2Targeted delivery using tissue-specific peptidomimetic ligandsGRADALIS INC·Filed 2012·Granted Nov 10, 2015·0 cites·35 claims
- 1660US2017175124A1Individualized cancer therapyGRADALIS INC·Filed 2016·Application pending·0 cites
- 1759US2015132843A1Processes for the Preparation of Highly Pure Plasmid CompositionsGRADALIS INC·Filed 2015·Application pending·0 cites
- 1859US2023144927A1Methods for the treatment of viral respiratory infectionsGRADALIS INC·Filed 2022·Application pending·0 cites
- 1957US2023338284A1Methods for the treatment of lung tumorsGRADALIS INC·Filed 2023·Application pending·0 cites
- 2052US2024189450A1Methods for treating cancersGRADALIS INC·Filed 2022·Application pending·0 cites
- 2151US2025313903A1Neoantigen immunotherapyGRADALIS INC·Filed 2025·Application pending·0 cites
- 2246US2013259925A1METHODS AND COMPOSITIONS TO TREAT CANCER USING BIFUNCTIONAL SRC 3 shRNAGRADALIS INC·Filed 2013·Application pending·0 cites
- 2346US2013259927A1Ewing's Sarcoma Bifunctional shRNA DesignGRADALIS INC·Filed 2013·Application pending·0 cites
- 2445US2014093888A1Highly pure plasmid dna preparationsGRADALIS INC·Filed 2013·Application pending·0 cites
- 2545US2013259926A1BI-FUNCTIONAL shRNA TARGETING MESOTHELIN AND USES THEREOFGRADALIS INC·Filed 2013·Application pending·0 cites
- 2641US2011081403A1Histone octamers for increased nucleic acid transferGRADALIS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GRADALIS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →